Amgen (AMGN)
$312.47
2.25 (0.71%)
AMGN Stock Quote Delayed 30 Minutes
Top 5 Stocks for 2024
INSIDE: Investing legend Louis Navellier reveals his Top 5 Stocks for 2024 — FREE!
Download His Free Report Here:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Unlock Louis Navellier's
? Stock Report – FREE:
Is ? a BUY?
Powered by Portfolio Grader
A
B
C
D
F
?
Unlock Louis Navellier's
? Stock Report to Find Out – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Investing legend Louis Navellier rates ? a "?." Unlock his ? Stock Analysis to find out why – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Fundamental Grade
Quantitative Grade
- Sales Growth ?
- Operating Margin Growth ?
- Earnings Growth ?
- Earnings Momentum ?
- Earnings Surprises ?
- Analyst Earnings Revisions ?
- Cash Flow ?
- Return on Equity ?
Previous Close
-
Market Cap
-
PE Ratio
-
EPS
-
Volume (Avg. Vol.)
1.97M
Day's Range
$310.37 - $315.28
52-Week Range
$211.71 - $329.72
Dividend & Yield
$8.52 (2.73%)
AMGN Stock Predictions, Articles, and Amgen News
Gilead Sciences Stock Is Back to Base — Go Long
Gilead stock is cheap selling at 11 price-earnings ratio. And it's coming into a long-term support zone. Catch the falling butter knife.
Will This FDA Approval Affect Amgen Stock Significantly?
AMGN stock is still riding on a rocky road despite news of a new FDA approval. Here's what Amgen investors need to know.
Trade of the Day: Amgen Is a Strong Stock in a Giddy Industry
AMGN stock has seen a steady incline since May and one that has good odds of continuing. This is sponsored by a general bid in the healthcare and biotechnology sectors.
These 9 Dividend Stocks Are About to Soar — Thanks to Donald Trump
There’s a lot uncertainty in today’s market, but one thing is guaranteed ... The new tax reform law is about to cause an avalanche of money to rush into dividend stocks in the weeks and months ahead.
5 Companies Making Giant Buybacks
Buybacks are quickly becoming a hot topic on Wall Street, and with buyback activity surging, it's important to find the best companies that are doing them the right way.
5 Cheap Large Cap Stocks to Buy Now
The tide has turned and the large caps are now under performing. Value investors should take a look. Compare Brokers....
Trade of the Day: Amgen, Inc. Clears a Breakout Hurdle
Large-cap biotech stocks as a group rallied along with the broader stock market on Wednesday. While so doing, some big names like AMGN stock broke past key near-term technical resistance.
Biotech ETFs Are the Best Way to Play the Recovering Sector
The biotech sector peaked in 2015. While it bounced back from lows, biotech ETFs give investors exposure to the sector as it recovers.
Amgen, Inc. (AMGN) Beats Q1 Estimates, Posts Weak F18 Guidance
Amgen (AMGN) had a mixed quarterly earnings report as the company topped analysts' earnings expectations, but its full-year outlook missed the mark.
7 Retirement Stocks for the Coming Correction
Defensive stocks are tough to find nowadays, but these seven retirement stocks offer long-term potential and some downside protection as well.
5 Cash-Rich Dividend Stocks to Buy
When it comes to dividend stocks, cash is king. These five stocks have huge cash balances and cash flows to keep the payouts coming.
The Amgen, Inc. Stock Spring Is About to Pop
Amgen stock is coiling like a spring. When the breakout comes, use AMGN call spreads to profit.
Sell for Amgen (AMGN) This Week
Amgen (AMGN) remains a Sell this week based on the latest market intelligence, and comparative pricing of its shares.
